Canagen India Pharmaceuticals Private Limited, a active private limited company, was established on 11 September 2018 in Navi Mumbai, Maharashtra, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U74999MH2018PTC313857. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹0.10 M.
Its leadership includes Suren Purshottam Mankani (Additional Director), Niket Kesarinath Mestry (Managing Director), Shubhangi Vishram Mestry (Director). Past directors included Kamal Ahad, Prabhakar Madhav Wazat, Niket Kesarinath Mestry. Its latest AGM occurred on 30 November 2021, with the balance sheet filed on 31 March 2021. It is based at Office 324, Vardhaman Market, Plot 75 Sector 17, Vashi, Navi Mumbai, Maharashtra, 400703.
U74999MH2018PTC313857
313857
11 September 2018
₹5.00 M
₹0.10 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Canagen India Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Suren Purshottam Mankani | Additional Director | 20 Dec 2021 | Current |
| Niket Kesarinath Mestry | Managing Director | 11 Sep 2018 | Current |
| Shubhangi Vishram Mestry | Director | 11 Sep 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 10 Jan 2019 | Past |
| Pramod Abcsdd | Chief Executive Officer | - | Past |
| Pramod Abcsdd | Director | 01 May 2019 | Past |
| Pramod Abcsdd | Director | 16 Jan 2019 | Past |
| Pramod Abcsdd | Director | 07 Oct 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Canagen India Pharmaceuticals Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a slight improvement in profitability, with a 8.59% increase in profit. The company's net worth observed a substantial decline by a decrease of 94.48%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2020, Canagen India Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Canagen India Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Canagen India Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Canagen India Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Suren Purshottam Mankani was appointed as a Additional Director was appointed as a Additional Director on 20 Dec 2021 & has been associated with this company since 3 years 11 months . was completed.
Progress on Canagen India Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Nov 2021 as per latest MCA records. was documented.
Canagen India Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Mumbai. was recorded as a recent event.
Niket Kesarinath Mestry was appointed as a Managing Director was appointed as a Managing Director on 11 Sep 2018 & has been associated with this company since 7 years 2 months . was recorded as a recent event.
Shubhangi Vishram Mestry was appointed as a Director was appointed as a Director on 11 Sep 2018 & has been associated with this company since 7 years 2 months . was recorded as a recent event.
Canagen India Pharmaceuticals Private Limited was registered on 11 Sep 2018 with Roc Mumbai & aged 7 years 2 months as per MCA records. was recorded as a recent event.
The CIN of Canagen India Pharmaceuticals Private Limited is U74999MH2018PTC313857.
Canagen India Pharmaceuticals Private Limited is headquartered at Office 324, Vardhaman Market, Plot 75 Sector 17, Vashi, Navi Mumbai, Maharashtra, 400703.
Canagen India Pharmaceuticals Private Limited was incorporated on 11 September 2018.
The current directors of Canagen India Pharmaceuticals Private Limited are
The primary industry of Canagen India Pharmaceuticals Private Limited is Pharma.
Canagen India Pharmaceuticals Private Limited is unlisted.
The authorized capital of Canagen India Pharmaceuticals Private Limited is ₹5.00 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX